期刊文献+

PDCA法在我院高危药品管理中的应用 被引量:27

Application of PDCA in the Management of High-alert Medications in Our Hospital
原文传递
导出
摘要 目的:探讨PDCA(计划、执行、检查、处理)法在医院高危药品管理中的应用和效果。方法:从某院高危药品目录的确定、摆放、调剂、使用、检查等方面建立高危药品管理制度;根据制度实施后出现的实际问题再采用PDCA法,以提高高危药品标识正确率为指标分析原因、拟定对策、定期检查效果并进行质量持续改进。结果:采取了完善高危药品管理制度、编制高危药品知识手册、加强全员培训及重点科室的检查等多项措施进行质量持续改进,使高危药品标识正确率由改进前的80%提高到改进后的100%。结论:该院建立的高危药品管理制度切实可行,且PDCA法能够促进高危药品的管理。 OBJECTIVE: To investigate the application and effect of PDCA management method (plan, do, check, action) in the management of hospital high-alert medications. METHODS: The management system of high-alert medications was established in respects of establishment of high-alert medicine list, arrangement, dispensary, application and examination. According to the problems of the management of high-alert medications, the project of increasing the accurate rate of high-alert medications logo was set up, and measures were made out on promotion followed by supervising the practice for continuous improvement using PD- CA. RESULTS: The countermeasures included improvir^g management system of high-alert medications, compiling information handbook, strengthening medical staff training and impoltant department checking, etc. After the implementation of PDCA cycle, the accurate rate of high-alert medications logo increased from 80% to 100%. CONCLUSIONS: Established management system of hospital high-alert medications is feasible and practical, and it can be improved by PDCA management method.
出处 《中国药房》 CAS CSCD 2013年第45期4261-4263,共3页 China Pharmacy
关键词 PDCA 高危药品 管理 质量持续改进 PDCA High-alert medications Manageaaent Continuous quality improvement
  • 相关文献

参考文献6

二级参考文献17

  • 1唐镜波,陈香谱,谭军,车艳.合理用药调研的国际指标[J].中国药房,1995,6(4):5-7. 被引量:176
  • 2Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients. Excess length of stay, ex- tra costs, and attributable mortality[J]. JAMA, 1997, 277 (4) : 301. 被引量:1
  • 3CuUen DJ, Sweitzer B J, Bates DW, et al. Preventable ad- verse drug events in hospitalized patients: a comparative study of intensive care and general care units[J]. Crit Care Med, 1997,25(8) : 1 289. 被引量:1
  • 4Bates DW, Spell N, Cullen D J, et al. The costs of adver- se drug events in hospitalized patients. Adverse Drug Events Prevention Study Group[J]. JAMA, 1997,277 (4) : 307. 被引量:1
  • 5Bates DW, Cullen D J, Laird N, et al. Incidence of adve- rse drug events and potential adverse drug events. Implica- tions for prevention. ADE Prevention Study Group[J]. JA- MA, 1995,274(1) :29. 被引量:1
  • 6Leape LL, Brennan TA, Laird N, et aL The nature of ad- verse events in hospitalized patients. Results of the Har- vard Medical Practice Study II [J]. NEngl J Med, 1991, 324(6) :377. 被引量:1
  • 7Belknap S. ' High-alert' medications and patient safety[J]. lntJQualHealth Care, 2001,13(4) : 339. 被引量:1
  • 8Cohen MR, Kilo CM. High-alert Medications:Safeguard- ing against Errors[M]. Washington, DC: American Phar- maceutical Association, 1999: 5.1-5.40. 被引量:1
  • 9Institute for Safe Medication Practices-ISME ISMP's list of high-alert medication[EB/OL ]. https://www.ismp.org/ Tools/highalertmedications.pdf.2012-05.2012-05-14. 被引量:1
  • 10Paparella S. High-alert medication: shared accountability for risk identification and error prevention[J]. J Emerg Nurs, 2010,36(5) : 476. 被引量:1

共引文献54

同被引文献200

引证文献27

二级引证文献241

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部